Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
bump near eye; This non-serious case was reported by a consumer via call center representative and described the occurrence of swelling in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (Shingles near eye). Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). On 18-MAR-2019, the patient received the 2nd dose of Shingrix. On an unknown date, 1 year after receiving Shingrix, the patient experienced swelling (Verbatim: bump near eye). The outcome of the swelling was not resolved. It was unknown if the reporter considered the swelling to be related to Shingrix. It was unknown if the company considered the swelling to be related to Shingrix. Additional Information: GSK Receipt Date: 29-JAN-2025 The patient self-reported this case for herself. The patient had a history of shingles, near her eye (did not mention a side). The patient had dose 2 of Shingrix. The patient state a year later she had a bump near her eye in the same place where she had shingles bump. It comes and goes and healthcare professional would order valacyclovir that she takes when it comes back. The patient's healthcare professional recommended she gets a booster of Shingrix.
Medical History/Concurrent Conditions: Shingles (Shingles near eye)